Home›Search›Inflammopharmacology

Inflammopharmacology

Springer Science and Business Media Deutschland GmbH · Switzerland

ISSN0925-4692eISSN1568-5608

SJR Q1✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q1+25

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.269

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

1.18

Total Works

2,876

Total Citations

57,289

2yr Mean Citedness

3.89

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope

Inflammopharmacology is a comprehensive resource on all aspects of inflammation and its pharmacological control, emphasizing pain therapy. Compares different inflammatory states and their causes. Examines the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions. Offers in-depth coverage of Conditional Pharmacology/Toxicology, Rheumatology, Gastroenterology, Neuro-Inflammation, and Novel Drugs, Natural Products and Nutraceuticals. Places particular emphasis on methods of measurement of clinical response effects of new agents and adverse effects from anti-rheumatic drugs. Focuses on the safety and efficacy of Non-prescription (OTC) and prescription NSAIDs and Analgesics.

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 25% in field

General Information

Country / RegionSwitzerland

Primary LanguageEnglish

1st Year Published—

FrequencySix No. A Year, 2002-

StatusActive

Total Publications2,876

Publisher OrgSpringer Nature

Visit Journal Website

Submission Info

Publishing ModelHybrid

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

⚡ Hybrid journal — subscription model available.

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Springer Science and Business Media Deutschland GmbH

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

0925-4692 / 1568-5608

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

PharmacologyQ1

Pharmacology (medical)Q1

ImmunologyQ2

Subject Classification

Web of Science Categories

ImmunologyToxicology

Scopus Categories

PharmacologyImmunologyPharmacology (medical)

Research Topics (OpenAlex)

Inflammatory mediators and NSAID effectsPharmacological Effects of Natural CompoundsRheumatoid Arthritis Research and TherapiesNatural product bioactivities and synthesisHelicobacter pylori-related gastroenterology studies